Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $92.42 USD
Change Today +3.94 / 4.45%
Volume 227.1K
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - ligand pharmaceuticals (LGND)

NameBoard RelationshipsTitleAge
John L. Higgins 34 RelationshipsChief Executive Officer and Executive Director45
Matthew W. Foehr 26 RelationshipsPresident and Chief Operating Officer42
Matthew Korenberg No RelationshipsChief Financial Officer and Vice President of Finance--
Charles S. Berkman J.D.No RelationshipsVice President, General Counsel and Secretary46

Board Members - ligand pharmaceuticals (LGND)

NameBoard RelationshipsPrimary CompanyAge
John W. Kozarich Ph.D.47 RelationshipsCorium International, Inc.66
John L. Higgins 34 RelationshipsLigand Pharmaceuticals Incorporated45
Jason M. Aryeh 25 RelationshipsJalaa Equities, L.P.47
Todd C. Davis 19 RelationshipsHealthCare Royalty Partners54
Stephen Lawrence Sabba M.D.11 RelationshipsQLT Inc.56

Executive Committees* - ligand pharmaceuticals (LGND)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeStephen Lawrence Sabba M.D. 11 Relationships3 Executives
Compensation CommitteeTodd C. Davis 19 Relationships3 Executives
Nominating CommitteeJason M. Aryeh 25 Relationships3 Executives
Corporate Governance CommitteeJason M. Aryeh 25 Relationships3 Executives
View LGND Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $92.42 USD +3.94

LGND Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $44.24 USD +0.67
Allergan plc $299.61 USD +5.40
Johnson & Johnson $93.35 USD +1.26
Pfizer Inc $31.97 USD +0.61
Valeant Pharmaceuticals International Inc C$308.00 CAD +11.80
View Industry Companies
 

Industry Analysis

LGND

Industry Average

Valuation LGND Industry Range
Price/Earnings 57.0x
Price/Sales 24.6x
Price/Book 25.4x
Price/Cash Flow 53.8x
TEV/Sales 19.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.